Alzheimer's Disease Trial, Not Yet Recruiting NCT07391436 Sponsor: Getúlio Vargas University Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07391436
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 65 years or older
  • People where a doctor suspects they may have mild cognitive impairment (MCI) or early Alzheimer's disease
  • People who are alert, aware of their surroundings, and able to answer questions
  • People who are willing and able to wear a monitoring device for 30 days
  • People who have signed the official consent form agreeing to take part

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have advanced dementia
  • People with a severe psychiatric condition that is not well controlled
  • People with severe vision or hearing difficulties that make communication impossible
  • People who are physically or cognitively unable to use wearable devices
  • People who have a pacemaker that is not compatible with the trial's devices
  • People whose diagnosis of MCI or early Alzheimer's disease is not confirmed during the study
  • People who choose to withdraw from the study at any point
  • People who pass away during the research period
  • People who do not use the wearable devices correctly or consistently as required
  • People who are unable or unwilling to complete all of the required tests and assessments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robson Luís Oliveira de Amorim, Getúlio Vargas University Hospital

Phone: +55 92 99403-4101

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Getúlio Vargas University Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 July 2027

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Accuracy of a Predictive Model for Identification of Mild Cognitive Impairment and Early Alzheimer's Disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov